Myron Evans, PhD
Academic Title: Assistant Professor, Pediatrics
Research Title: Principal Investigator, Ben Towne Center for Childhood Cancer Research
Research Center: Ben Towne Center for Childhood Cancer Research
"My passion is to ensure that children diagnosed with cancer live healthy, long lives and grow up to become exactly who they want to be. Our research focuses on better understanding brain tumors and developing new therapies to destroy cancer cells. Our team combines a love of science, passion, and creativity (and a strong cup of coffee) to bring hope to patients and their families."
I am a basic and translational scientist, diversity advocate, and champion for children with cancer. My research focuses on understanding the mechanisms underlying both normal brain development and tumor initiation/progression in pediatric central nervous system (CNS) tumors, such as medulloblastoma and diffuse midline glioma. Our hope is to identify new targets that are tumor-specific that can be used as opportunities to target cancer cells, while sparing normal developing brain cells.
Dr. Evans completed his graduate work at Duke University studying therapy resistance in adult breast cancer. His postdoctoral fellowships were completed at St. Jude Children's Research Hospital where he studied epigenetic regulation of CNS development and pediatric solid tumor initiation.
Dr. Evans joined Seattle Children’s in 2021. He is a principal investigator at the Seattle Children’s Research Institute Ben Towne Center for Childhood Cancer Research, an assistant professor in the Department of Pediatrics at the University of Washington and an affiliate assistant member at Fred Hutchinson Cancer Center in the Human Biology Division.
The Myron Evans Lab is working to better understand why children get brain tumors and which mutations drive those tumors. Our ultimate goal is to make discoveries that inform a new wave of brain tumor treatments that are more targeted than today’s therapies, with fewer side effects.
- Research Description
Dr. Evans' independent lab at Seattle Children's Research Institute centers around the field of developmental oncology studying the epigenetic regulation of CNS development in the post-natal mammalian brain. His lab studies how these epigenetic mechanisms are deregulated and contribute to the formation of pediatric brain tumors. By identifying tumor-specific vulnerabilities, the Evans Lab can design and test new therapies for childhood cancer patients that spare normal cells.